Document Type
Article
Abstract
Alzheimer’s Disease is the 5th leading cause of death for Americans 65 and older Treatment The U.S. Food and Drug Administration Only five drugs approved that “temporarily slow worsening of symptoms for about six to 12 months.” Effective for only about half of all patients.
Publication Date
Spring 5-21-2012
Recommended Citation
Middleton, Kirsten; Zhang, Guo-ping; and George, Thomas F., "Electronic properties of memantine (Alzheimer's disease) and amantadine (anti-flu) drugs" (2012). Symposium 2012. 3.
https://scholars.indianastate.edu/symposium/3
Included in
Medicinal and Pharmaceutical Chemistry Commons, Natural Products Chemistry and Pharmacognosy Commons, Neurosciences Commons, Organic Chemistry Commons, Pathological Conditions, Signs and Symptoms Commons
Comments
Faculty Sponsor: Guo-ping Zhang